WWW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WWW is not a good buy right now for an impatient buyer. The technical trend is still bearish (price below key pivot with bearish moving-average stack), recent analyst actions skew negative (multiple downgrades and price-target cuts), and there are no Intellectia buy signals today to override those factors. With earnings coming pre-market on 2026-02-23, the near-term setup is more “avoid/stand aside” than “buy now.”
Trend/Setup: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating the broader downtrend remains intact. MACD histogram is negative (-0.165) but contracting, suggesting downside momentum is easing, not reversing yet. RSI(6)=44.1 is neutral-to-weak (no oversold bounce signal). Key levels: Pivot 18.141 is the immediate reclaim level; price (17.74) is below it. Support sits at S1=17.104 then S2=16.463; resistance at R1=19.177 then R2=19.818. A clean break below ~17.10 increases risk of a quick move toward mid-16s. Quant pattern read: Similar-pattern stats imply modest near-term weakness (-0.77% next day, -2.09% next week) before a potential 1-month rebound (+3.35%), but the current tape still favors downside/mean-reversion risk rather than a clean upside trend.
Intellectia Proprietary Trading Signals
than resistance, so a short-term reflex rally is possible if support holds.
on 2026-02-23 pre-market could drive a gap move; without a bullish setup, this is more risk than catalyst for an impatient entry.
Latest quarter: 2025/Q3. Revenue grew to $470.3M (+6.84% YoY), net income rose to $24.4M (+7.02% YoY), EPS increased to $0.30 (+7.14% YoY), and gross margin improved to 47.46 (+4.88% YoY). Overall: steady YoY improvement and margin expansion, but the market/analysts are still focused on channel mix (notably DTC softness) and sustainability of the recovery.
Recent trend: Net negative. Since early Jan 2026, Wolverine saw several downgrades (Piper Sandler to Neutral with PT cut to $16; BNP Paribas to Neutral with $19; Argus to Hold), following broad PT cuts after Q3 (Nov 2025). UBS remains a notable bullish outlier (Buy, PT reduced but still much higher previously). Wall Street pros: improving YoY financials and margin expansion; potential multi-year EPS momentum if consumer demand holds and execution improves. Wall Street cons: DTC weakness and brand challenges (Wolverine/Sweaty Betty), wholesale/macro headwinds, and tariff pressure still ahead; stock viewed as fairly valued by at least one firm after the move.
